/Companies

Nucleus

2 known investors

Find your way into Nucleus

Sign up to see every warm intro you have to Nucleus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nucleus team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nucleus is a venture studio that launches, acquires, and partners with brands and technologies focused on mental wellness and the psychedelic medicine industry. Its offerings span a proprietary data platform (Neuly), clinical trial management, financial intelligence, marketing, and education tools serving companies and practitioners across the psychedelic medicine value chain.

Investors · 2

Frequently asked questions

What does Nucleus do?
Nucleus is a venture studio that launches, acquires, and partners with brands and technologies focused on mental wellness and the psychedelic medicine industry. Its offerings span a proprietary data platform (Neuly), clinical trial management, financial intelligence, marketing, and education tools serving companies and practitioners across the psychedelic medicine value chain.
Who are Nucleus's investors?
Nucleus's investors include Delta-v Capital, Iter Investments.